熊去氧膽酸市場：按劑型、萃取方法、應用、通路和地區分類

2025 年全球熊去氧膽酸市場規模估計為 6.515 億美元，預計到 2032 年將達到 13.031 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 10.4%。

數字。 2025 年熊去氧膽酸各地區市場佔有率（%）

熊去氧膽酸是肝臟產生的膽汁酸，有助於攝取的脂肪的消化和吸收。它用於治療各種肝臟相關疾病，如原發性膽汁性肝硬化 (PBC) 和膽結石。全球熊去氧膽酸市場的成長是由肝病盛行率的上升和對熊去氧膽酸在治療中的好處的認知的提高所推動的。市場參與企業正在大力投資研發，以開發新的配方和上市形式的熊去氧膽酸，以擴大消費群。

市場動態

全球熊去氧膽酸市場的成長得益於易患肝損傷的老年人口不斷增加、新興市場醫療保健支出不斷增加以及熊去氧膽酸作為 PBC 一線藥物的應用日益廣泛。然而，高昂的治療費用和替代治療方案的可用性可能會阻礙市場的成長。針對特定適應症的熊去氧膽酸製劑的開發和提高生物有效性的新技術的出現為市場相關人員提供了高成長機會。嚴格的藥品核准規定可能會阻礙市場的成長。

研究的主要特點

本報告對全球熊去氧膽酸市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和復合年成長率 (CAGR%)。

它揭示了不同領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球熊去氧膽酸市場的主要企業根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行分析。

本研究涉及的主要企業包括 Dr. Falk Pharma、Daewoong Pharmaceutical、Teva Pharmaceutical、Mitsubishi Tanabe Pharma、Lannett Company 等。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、規模擴大、市場擴張和行銷策略做出明智的決策。

全球熊去氧膽酸市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過分析全球熊去氧膽酸市場所使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

4. 全球熊去氧膽酸市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020-2032 年全球熊去氧膽酸市場（以劑型分類）（百萬美元）

• 介紹
• 固態的
• 液體

6. 2020-2032 年全球熊去氧膽酸市場（以萃取方法分類）（百萬美元）

• 介紹
• 合成
• 生物

7. 2020 年至 2032 年全球熊去氧膽酸市場（按應用分類）（百萬美元）

• 介紹
• 胃腸道疾病
• 肝臟疾病
• 囊腫纖維化
• 其他

8. 2020-2032 年全球熊去氧膽酸市場按分銷管道分類（百萬美元）

• 介紹
• 醫院藥房
• 零售藥局
• 網路藥局

9. 2020-2032 年全球熊去氧膽酸市場（按地區分類）（百萬美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第10章 競爭格局

• 公司簡介
  • Dipharma Francis Srl
  • ERREGIERRE SpA
  • Grindeks
  • Industria Chimica Emiliana
  • Mitsubishi Tanabe Pharma Corporation
  • Zhongshan Belling BIoTechnology Co.
  • Glenmark Pharmaceutical Limited
  • Abil Chempharma Private Limited
  • BIoTavia Labs Pvt Ltd
  • Daewoong Bio Inc.
  • PharmaZell GmbH
  • Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
  • Dr. Falk Pharma
  • Teva Pharmaceuticals
  • Epic Pharma
  • Lannett Company, Inc.
  • Mylan NV
  • Bruschettini SpA
  • Impax Laboratories, Inc.
  • Shanghai Pharma

第 11 章 分析師建議

• 興衰
• 一致的機會地圖

第 12 章參考文獻與調查方法

• 參考
• 調查方法

Global Ursodeoxycholic Acid Market is estimated to be valued at USD 651.5 Mn in 2025 and is expected to reach USD 1,303.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Figure. Ursodeoxycholic Acid Market Share (%), By Region 2025

Ursodeoxycholic acid is a bile acid produced by the liver that helps in digestion and absorption of consumed fats. It is prescribed for treating various liver related conditions such as primary biliary cirrhosis (PBC) and gallstones. Global ursodeoxycholic acid market growth is driven by rising prevalence of liver diseases and increasing awareness about benefits of ursodeoxycholic acid in their treatment. The market players are investing heavily in R&D to develop new formulations and delivery forms of ursodeoxycholic acid to expand consumer base.

Market Dynamics:

Global ursodeoxycholic acid market growth is driven by rising geriatric population prone to developing liver disorders, increasing healthcare expenditure in developing nations, and growing adoption of ursodeoxycholic acid as first line therapy for PBC. However, high treatment costs and availability of alternative treatment options can hamper the market growth. Development of ursodeoxycholic acid formulations targeted towards specific indications and emergence of novel technologies for enhancing its bioavailability present high growth opportunities for market players. Stringent regulations for drug approvals can hamper the market growth.

Key features of the study:

This report provides in-depth analysis of the global ursodeoxycholic acid market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global ursodeoxycholic acid market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, and Lannett Company

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global ursodeoxycholic acid market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ursodeoxycholic acid market

Detailed Segmentation-

• Dosage Form Insights (Revenue, USD Mn, 2020 - 2032)
  • Solid Dosage Form
  • Liquid Dosage Form
• Mode of Extraction Insights (Revenue, USD Mn, 2020 - 2032)
  • Synthetic
  • Biological
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Gastrointestinal Disorders
  • Liver Disorders
  • Cystic Fibrosis
  • Others
• Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals and Clinics
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Mn 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Dipharma Francis Srl
  • ERREGIERRE S.p.A.
  • Grindeks
  • Industria Chimica Emiliana
  • Mitsubishi Tanabe Pharma Corporation
  • Zhongshan Belling Biotechnology Co.
  • Glenmark Pharmaceutical Limited
  • Abil Chempharma Private Limited
  • Biotavia Labs Pvt Ltd
  • Daewoong Bio Inc.
  • PharmaZell GmbH
  • Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
  • Falk Pharma
  • Teva Pharmaceuticals
  • Epic Pharma
  • Lannett Company, Inc.
  • Mylan N.V.
  • Bruschettini S.p.A.
  • Impax Laboratories, Inc.
  • Shanghai Pharma

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Dosage Form
  • Market Snapshot, By Mode of Extraction
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Ursodeoxycholic Acid Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Ursodeoxycholic Acid Market, By Dosage Form, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Solid Dosage Form
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Liquid Dosage Form
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Ursodeoxycholic Acid Market, By Mode of Extraction, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Synthetic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Biological
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Ursodeoxycholic Acid Market, By Application, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Gastrointestinal Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Liver Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cystic Fibrosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Ursodeoxycholic Acid Market, By Distribution Channel, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Ursodeoxycholic Acid Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Dipharma Francis Srl
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ERREGIERRE S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Grindeks
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Industria Chimica Emiliana
  • Mitsubishi Tanabe Pharma Corporation
  • Zhongshan Belling Biotechnology Co.
  • Glenmark Pharmaceutical Limited
  • Abil Chempharma Private Limited
  • Biotavia Labs Pvt Ltd
  • Daewoong Bio Inc.
  • PharmaZell GmbH
  • Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
  • Dr. Falk Pharma
  • Teva Pharmaceuticals
  • Epic Pharma
  • Lannett Company, Inc.
  • Mylan N.V.
  • Bruschettini S.p.A.
  • Impax Laboratories, Inc.
  • Shanghai Pharma

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact